NDC 70842-102 – Baxdela

Delafloxacin Meglumine 300 mg/10.5mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC70842-102

Product details

Brand name
Baxdela
Generic name
Delafloxacin meglumine
Labeler
Melinta Therapeutics, LLC
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
NDA · NDA208611
Marketed since
June 19, 2017
Listing expires
December 31, 2026
Pharmacologic class
Fluoroquinolone Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Baxdela →

Package NDC codes (1)

Package NDCDescriptionSince
70842-102-0310 VIAL, GLASS in 1 CARTON (70842-102-03) / 10.5 mL in 1 VIAL, GLASS (70842-102-01)Jun 19, 2017

Other Baxdela products